Real-World Study on the Burden of Hidradenitis Suppurativa
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 100
- Primary Endpoint
- To estimate work productivity loss in patients with HS.
Study Overview
Brief Summary
Despite the significant impact of HS on patients' quality of life (QoL) and daily functioning, there remains limited real-world evidence describing the burden of this condition in Canada. HS is an under-recognized and often misdiagnosed condition, with a substantial psychological and physical burden on patients. Understanding the real-world experiences of individuals living with HS in Canada can help identify unmet needs and inform patient-centered care approaches.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patient diagnosed with HS;
- •Aged ≥18 years;
- •Able to read and understand French or English;
- •Willing and able to provide written informed consent.
Exclusion Criteria
- •1. Participation in an interventional study for HS.
Arms & Interventions
Patient with HS
Patient diagnosed with HS
Intervention: No Intervention: Observational Cohort (Other)
Outcomes
Primary Outcomes
To estimate work productivity loss in patients with HS.
Time Frame: At recruitment
Using the Work Productivity and Activity Impairment (WPAI) questionnaire. This questionnaire provides a quantitative measure of impairment over the last 7 days and includes four metrics: absenteeism (work time missed because of health issues during the past 7 days), presenteeism (impairment while working due to health issues during the past 7 days), overall work productivity loss (combination of absenteeism and presenteeism), and activity impairment.
Secondary Outcomes
- To estimate the QoL of patients with HS(At recruitment)
- To estimate pain intensity in patients with HS.(At recruitment)